Related Experiment Videos

[The action of the yeast preparation Perenterol (author's transl)]

MMW, Munchener Medizinische Wochenschrift
|January 17, 1975
PubMed

Insights

Living Saccharomyces cerevisiae yeast in capsules can successfully treat gastro-intestinal dysbiosis without chemotherapy. This nonpathogenic yeast does not overgrow or harm other gut microorganisms.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pharmacology

Background:

  • Dysbiosis, an imbalance in gut microbiota, is linked to various gastro-intestinal disorders.
  • Current treatments for dysbiosis often involve chemotherapeutic agents with potential side effects.

Purpose of the Study:

  • To evaluate the efficacy of a living yeast preparation, Perenterol, for treating dysbiotic conditions.
  • To assess the safety profile of administering live Saccharomyces cerevisiae.

Main Methods:

  • A lyophilized preparation of a living Saccharomyces cerevisiae strain was administered in gelatin capsules.
  • Each capsule contained 1 x 10^9 organisms.
  • Treatment was administered for dysbiotic conditions of the gastro-intestinal tract.

Main Results:

  • Perenterol demonstrated successful treatment of gastro-intestinal dysbiotic conditions.
  • The administration of living, nonpathogenic yeast did not lead to overgrowth or suppression of other microorganisms.
  • Effective treatment was achieved without the concurrent use of chemotherapeutic agents.

Conclusions:

  • Living Saccharomyces cerevisiae (Perenterol) is an effective and safe therapeutic option for gastro-intestinal dysbiosis.
  • This probiotic yeast offers a non-chemotherapeutic approach to restoring gut balance.
  • The nonpathogenic nature of the yeast ensures host safety and microbial ecosystem stability.

Related Concept Videos